The present invention relates to compounds of the formula (I): to pharmaceutically acceptable salts therefore and to pharmaceutically acceptable solvates of said compounds and salts, wherein the substituents are defined herein; to compositions containing such compounds; and to the uses of such compounds in the treatment of various diseases, particularly inflammatory conditions.
-
Page/Page column 58-59
(2010/12/17)
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
-
Page 153
(2008/06/13)
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
-
Page 153
(2008/06/13)
More Articles about upstream products of 473733-69-6